Project Grant K01DA058807
Award Date
8/1/24
Completion Date
7/31/29
Dollars Obligated
$181K
Federal Agency
National Institute on Drug Abuse
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
West Haven, CT 06516, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $357,613 to Yale University to conduct research aimed at improving the understanding of the genetic mechanisms underlying substance use disorders (SUDs). The key objectives of this 2-year project are to: 1) leverage large-scale whole-genome sequencing (WGS) datasets to identify novel rare and common genetic variants associated with SUDs and recover...
The National Institute on Drug Abuse (NIDA) awarded a $267,696 Project Grant under CFDA 93.279 - Drug Use and Addiction Research Programs to the University of Massachusetts Lowell (UML), a minority-serving institution, for the project "Enhancing Opportunities for Addiction Research in the Merrimack Valley." The project aims to expand UML's existing Public Health Informatics and Technology (PHIT) program by creating a new PHIT-AR (Addiction Research) track. This will recruit diverse...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will support a $346,911 cross-species research study to identify early life environmental and genetic risk factors for substance use disorders (SUDs). The key objectives are to: 1) determine how early life environment influences neurocognitive development and its relationship to adult impulsivity behaviors; 2) identify genomic networks associated...
This Project Grant award of $288,107 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) is funding a 5-year predoctoral training program at the Scripps Research Institute. The program aims to develop a new generation of leaders equipped with technical skills and expertise in team science to translate research discoveries into potential treatments for substance use disorders. Key elements include: Mentorship from experts across...
This Project Grant award of $207,910 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a 3-year training program for a graduate student at the University of Michigan to research shared neurobiological mechanisms that can confer vulnerability to addiction and comorbid psychiatric disorders such as post-traumatic stress disorder. The project will utilize chemogenetic and fiber photometry techniques to examine the...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a multivariate genome-wide association analysis of opioid-related traits in a diverse population of over 500,000 individuals. The $715,238 award, effective January 15, 2025 through November 30, 2029, will enable researchers at the University of California, San Diego to investigate the genetic basis of pre-addiction opioid use stages,...
This $196,350 Project Grant was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to Yale University. The grant will fund a project titled "HIV COMPLEX CAUSAL MODELING: GUT MICROBIOME, DRUG USE, AND IMMUNE RESPONSES" from August 1, 2024 to July 31, 2026. The project aims to elucidate the causal relationship between drug use disorders, HIV acquisition, gut microbiome, and immune responses using Mendelian randomization...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,032,192 to Yale University to conduct research on the cell-type specific epigenomic effects of cannabis use in people living with HIV. The project aims to dissect the interactions between HIV infection and cannabis use, and identify potential druggable targets through comprehensive profiling of DNA methylation across different cell types. The...
The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $809,922 Project Grant to the University of Colorado-Denver to support the "PREPARING INDIGENOUS SCIENTISTS TO LEAD INNOVATIVE SUBSTANCE USE RESEARCH: THE NATIVE CHILDREN'S RESEARCH EXCHANGE SCHOLARS PROGRAM". This grant, effective from September 1, 2024 to June 30, 2025, aims to foster the development of early career Indigenous substance use and disorder...
This Project Grant award for $155,140 from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), supports research at Rutgers, The State University of New Jersey to explore the relationships between substance use disorders (SUDs) and other forms of psychopathology. The 5-year project aims to: Use advanced quantitative methods to model the phenotypic overlap between SUDs and other mental health conditions. Identify and...